p56/p53lyn tyrosine kinase activation in mammalian cells treated with mitomycin C

S Kharbanda1, Z M Yuan, N Taneja

  • 1Division of Cancer Pharmacology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115.

Oncogene
|October 1, 1994
PubMed

Insights

Mitomycin C (MMC) activates p56/p53lyn tyrosine kinase in leukemia cells, unlike other kinases. This activation is linked to the cell cycle protein p34cdc2, potentially impacting DNA damage response.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Genotoxic agents like mitomycin C (MMC) can induce cellular responses.
  • Protein tyrosine kinases play crucial roles in cell signaling pathways.
  • The activation of specific kinases in response to DNA damage is not fully understood.

Purpose of the Study:

  • To investigate the effects of mitomycin C (MMC) on Src-like protein tyrosine kinases in HL-60 myeloid leukemia cells.
  • To determine the role of p56/p53lyn activation in cellular response to alkylating agents.
  • To elucidate the interaction between activated p56/p53lyn and cell cycle regulatory proteins.

Main Methods:

  • Treatment of HL-60 cells with mitomycin C and other alkylating agents.
  • Assessing the activity of protein tyrosine kinases (p59fyn, pp60c-src, p56/p53lyn) using biochemical assays.
  • Utilizing tyrosine kinase inhibitors (herbimycin A, genistein) to study kinase sensitivity.
  • Employing glutathione S-transferase (GST)-Lyn fusion protein for interaction studies.
  • Performing coimmunoprecipitation and in vitro kinase assays to confirm protein associations and phosphorylation sites.

Main Results:

  • Mitomycin C did not induce p59fyn or pp60c-src activity but rapidly activated p56/p53lyn.
  • Activation of p56/p53lyn involved increased autophosphorylation and sensitivity to kinase inhibitors.
  • p56/p53lyn was found to interact with the cell cycle protein p34cdc2.
  • p34cdc2 showed increased tyrosine phosphorylation upon MMC exposure, with p56/p53lyn phosphorylating Tyr-15 in vitro.

Conclusions:

  • The cellular response to mitomycin C involves the activation of p56/p53lyn.
  • p56/p53lyn activation and its interaction with p34cdc2 may be involved in the DNA damage-dependent mitotic checkpoint signaling.
  • These findings provide insights into the molecular mechanisms of DNA damage response pathways in leukemia cells.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...